Mitochondrial Transplantation - From Animal Studies to Clinical Relevance
The Scientific Committee of WMS is honored to announce that Dr. James McCully, from the Harvard Medical School Department of Cardiac Surgery Boston Children’s Hospital, USA, will be joining us for our 10th Anniversary Edition of Targeting Mitochondria World Congress, which will be held in Berlin on October 28th-29th, 2019.
In his presentation entitled "Mitochondrial Transplantation - From Animal Studies to Clinical Relevance", Dr. McCully will share his studies using a novel therapy for cardioprotection based on mitochondrial transplantation. This approach uses replacement of native mitochondria damaged by ischemia/reperfusion injury with viable, respiration-competent mitochondria isolated from non-ischemic skeletal muscle tissue, obtained from the patient’s own body. Dr. McCully will provide results and insight from ischemia/ reperfusion protocols in regionally ischemic animal heart models and from a Phase 1 clinical trial in pediatric patients requiring institution of extracorporeal membrane oxygenation support.
For more information about Targeting Mitochondria 2019: https://targeting-mitochondria.com
Mitochondria-targeted low-molecular weight compounds for probing mitochondrial function
The Scientific Committee of WMS is honored to announce that Prof. Richard C. Hartley, Professor of Chemical Biology from University of Glasgow, United Kingdom, will be joining us for our 10th Anniversary Edition of Targeting Mitochondria World Congress, which will be held in Berlin on October 28th-29th, 2019.
During the Congress Prof. Richard C. Hartley will speak about "Mitochondria-targeted low-molecular weight compounds for probing mitochondrial functions".
The Hartley group specializes in designer small molecules targeted to accumulate in the mitochondrial matrix. These can be used both to detect and manipulate mitochondrial redox processes. Examples include compounds for mitochondrial superoxide detection (MitoNeoD) and generation (MitoPQ), for selective depletion of mitochondrial antioxidant defences (MitoCDNB), and for mitochondrial protection (MitoGamide). Synthetic chemicals can also be used to mimic mitochondrial signaling and modulate inflammatory responses (octyl itaconate).
For more information about Targeting Mitochondria 2019: https://targeting-mitochondria.com
The brain MITOxy project : from mitochondria to proteases and reactive species interactome
Dr. Laurent Chatre from CNRS, University of Caen-Normandie, France will join Targeting Mitochondria 2019 congress.
Dr. Chatre will discuss our current studies on the relationship between mitochondria, serine proteases and the reactive species interactome (RSI) in normal and pathological conditions related to hypoxia in the brain.
For more information about Targeting Mitochondria 2019: https://targeting-mitochondria.com
Cannabinoids and skin: The "C(ut)annabinoid" system as a novel player in regulating cutaneous mitochondrial biology by Dr. Oláh
During the specical session dedicated to the Mitochondria and Skin, Dr. Attila Oláh from University of Debrecen, Hungary will give a presentation entitled "Cannabinoids and skin: The "C(ut)annabinoid" system as a novel player in regulating cutaneous mitochondrial biology".
According to Dr. Oláh:
Although the mitochondrial biology of the skin is a relatively less-studied area of the field, a growing body of evidence suggests that it is profoundly involved in the regulation of several aspects of cutaneous physiology, including, but not limited to hair growth, epidermal differentiation and (photo) aging. The current talk intends to provide a brief overview of recent literature data with promising translational potential, and to highlight the potential role of the cutaneous cannabinoid (“C(ut)annabinoid”) system in controlling mitochondrial activity in the skin.
For more information about Targeting Mitochondria 2019: www.targeting-mitochondria.com
Mitochondria and Skin: Mitochondria in Wound Healing
During Targeting Mitochondria 2019, a Special session will be dedicated to Mitochondria, Metabolism and Skin.
One of the speakers of this session is Dr. Jakob Wikström from Karolinska University Hospital, Sweden and present his research work entitled "Mitochondria and Skin: Mitochondria in Wound Healing".
Dr. Jakob Wikström: "Healing of common chronic skin leg ulcers in the elderly requires ATP to regenerate lost tissue. While wound oxygen treatment has been investigated in depth the role of the oxygen recipient – mitochondria – has gotten little attention. Here we present our results on the role of mitochondria in human wound healing".
For more information about Targeting Mitochondria 2019: www.targeting-mitochondria.com
Mitochondrial damage and renewal in Wilson disease will be presented by Prof. Hans Zischka
Prof. Hans Zischka from Institute of Molecular Toxicology and Pharmacology, Germany will speak about "Mitochondrial damage and renewal in Wilson disease".
Wilson disease (WD) is a hereditary defect in the metabolism of copper. Here, the liver is unable to eliminate excess copper causing its accumulation primarily in liver and brain. In neurons and hepatocytes, a rising copper overload particularly damages their mitochondria. However, sometimes years pass before cell death occurs, suggesting the possible existence of intracellular protective mechanisms that can counteract such mitochondrial poisoning.
Prof. Zischka examined cell cultures from WD patients but also WD rodent models for their reaction to copper.
He observed that the hepatocytes reacted to copper overload with an intensification of the mechanisms support autophagy. Particularly, the copper-overloaded mitochondria are affected by this process (in this case called mitophagy). However, mitophagy helps only up to a certain level of copper overload and other treatments need to be employed to avoid cell death. Nevertheless, these results demonstrate the potential for cell regeneration resulting from auto-/mitophagy, which could be also relevant for other disorders that arise or are paralleled by cell-toxic metal accumulations.
For more information about Targeting Mitochondria 2019: www.targeting-mitochondria.com
Mitochondria and Skin: A dedicated session during Targeting Mitochondria 2019
Dr. Sibylle Jäger from L’Oréal Research & Innovation, France will join the Targeting Mitochondria 2019 Congress and speak about a dedicated session during "Role of PGC-1s in human epidermal physiology".
During Targeting Mitochondria 2019, a Special session will be dedicated to Mitochondria, Metabolism and Skin. One of the speakers of this session will be Dr. Sibylle Jäge.
She will highlight: "Altered metabolism is a hallmark of aging, and key regulators of metabolism, notably members of the peroxisome proliferator activated receptor gamma coactivator (PGC)-1 family have been implicated in aging and its associated conditions. However, the roles of PGC-1s in skin physiology and aging have been largely unexplored. She investigated the potential role of PGC-1s in skin using human epidermal primary keratinocytes and living epidermal equivalents. Overall, her results show that PGC-1s are essential components of epidermal physiology, revealing a novel axis that could be targeted in skin conditions and aging".
For more information about Targeting Mitochondria 2019: www.targeting-mitochondria.com
Role of actin-regulating proteins on mitochondria - Introduction by Prof. Cartrsten Culmsee
The Scientific Committee of WMS is honored to announce that Prof. Cartrsten Culmsee from University of Marburg, Germany will be joining us for our 10th Anniversary Edition of Targeting Mitochondria World Congress, which will be held in Berlin on October 28th-29th, 2019.
During the Congress Prof. Culmsee will introcuce "Role of actin-regulating proteins on mitochondria".
For more information about Targeting Mitochondria 2019: https://targeting-mitochondria.com
